GLENDALE, Calif., Oct. 21, 2014 /PRNewswire/ -- Apollo Medical Holdings, Inc. (ApolloMed) (OTC-QB: AMEH), an integrated physician-centric healthcare delivery company, today announced the appointment of David M. Badour as Senior Vice President of Business Development.

Mr. Badour is a seasoned healthcare executive with close to 20 years of experience and a proven track record of business development strategies for healthcare organizations.  He has held executive business development positions with multiple healthcare organizations, including companies focused on hospitalist services, emergency department staffing, hospital pharmacy management and urgent care centers, successfully working to increase revenues and profits.

Prior to joining ApolloMed, Mr. Badour was Regional Sales Director for CompleteRx, a hospital pharmacy management services company based in Houston, Texas.  At CompleteRx, he had principal responsibility for growing the company's customer base on the West Coast. Prior to joining CompleteRx, he was Regional Vice President for Business Development for Sound Physicians, a hospitalist staffing company in Tacoma, Washington. At Sound, he was responsible for generating sales of new hospitalist programs on the West Coast.

Previously, he was Vice President of Business Development for Emergency Physicians Medical Group in Ann Arbor, Michigan, from 2002 to 2006.  At EPMG, Mr. Badour met or exceeded 100% of quota each fiscal year and developed and implemented change management strategies.  Prior to this, he was the National Account Sales Manager for Concentra Medical Centers, which operates over 300 urgent care centers, from 1999 to 2001.   At Concentra, he directed a team of five sales representatives and several support staff, including all sales and marketing initiatives in the Midwest region, and managed a multi-million dollar annual budget that increased year-over-year.

"This is an exciting opportunity to join a company that is working to change the way in which healthcare is managed in order to provide patients with better long-term outcomes," stated David Badour.  "ApolloMed is becoming a leader in the field of integrated healthcare delivery, and I look forward to helping the team increase its presence in both the Southern California region, as well as throughout the United States."

"David's unique skill set and insights from years of experience, ranging from strategic planning to brand management and business development, will enhance our efforts to accelerate growth," stated Warren Hosseinion, M.D., Chief Executive Officer.  "He will be an outstanding addition to our leadership team as we continue to expand our reach and work with physicians, health plans and hospitals to further enhance patient care in an effective and cost-efficient manner."

Mr. Badour earned a B.A. in Economics and Management from Albion College in Albion, Michigan.  He is an affiliate member of the American College of Healthcare Executives and San Diego Organization of Healthcare Leaders.

About Apollo Medical Holdings, Inc. (ApolloMed)
ApolloMed is a leading integrated physician-centric healthcare delivery company commited to providing exceptional multi-disciplinary care in the communities it serves.  ApolloMed is addressing the healthcare needs of the nation's largest population center by leveraging its integrated healthcare delivery platform comprised of four affiliated and complementary physician groups:  ApolloMed Hospitalists, ApolloMed ACO (Accountable Care Organization), Maverick Medical Group (Independent Physician Association) and ApolloMed Care Clinics.  ApolloMed strives to improve medical outcomes with high-quality, cost-efficient care.  For more information, please visit www.apollomed.net.

Forward Looking Statements
This press release may contain forward-looking statements, including information about management's view of future expectations, plans and prospects for Apollo Medical Holdings, Inc. ("the Company").  In particular, when used in the preceding discussion, where we refer to quarter over quarter revenue growth targeted for the remainder of 2014 and the words "predicts," "believes," "expects," "intends," "seeks," "estimates," "plans," "anticipates," and similar conditional expressions or future or conditional verbs such as "will," "may," "might," "should," "would" and "could" are intended to identify forward-looking statements.  In addition, our representatives may from time to time make oral forward-looking statements.  Any such statements, other than those of historical fact, about an action, event or development, are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company's management.  Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance or achievements of the Company, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends.  Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company's actual results, performance or achievements may vary materially from those described in the relevant forward-looking statement as being expected, anticipated, intended, planned, believed, sought, estimated or projected.  Unknown or unpredictable factors also could have material adverse effects on the Company's future results.  The forward-looking statements included herein are made only as of the date hereof.  The Company cannot guarantee future results, levels of activity, performance or achievements.  Accordingly, you should not place undue reliance on these forward-looking statements.  Finally, the Company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under Item 1A. "Risk Factors" of the Company's Annual Report on Form 10-K for the year ended January 31, 2014 and in any of the Company's other subsequent Securities and Exchange Commission filings.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT
The Ruth Group
David Burke
646-536-7009 or via email at dburke@theruthgroup.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/apollo-medical-holdings-appoints-david-m-badour-as-senior-vice-president-of-business-development-596629520.html

SOURCE Apollo Medical Holdings, Inc.